The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glee, P. M.
Right arrow Articles by Cutler, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glee, P. M.
Right arrow Articles by Cutler, J. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1999, 163: 826-833.
Copyright © 1999 by The American Association of Immunologists

Peptide Ligands That Bind IgM Antibodies and Block Interaction with Antigen1

Pati M. Glee2, Seth H. Pincus, Deirdre K. McNamer, Michael J. Smith, James B. Burritt and Jim E. Cutler

Department of Microbiology, Montana State University, Bozeman, MT 59717

We have selected a peptide-display phage library on IgM Abs and identified a panel of phage-expressing peptides that bind to IgM Abs in general, but not to Abs of other classes. A synthetic peptide corresponding to one of the displayed peptide sequences also binds to IgM Abs. The peptides bind to both soluble pentameric Abs and to monomeric cell-surface IgM. The phage-displayed and synthetic peptides inhibit the binding of IgM Abs to Ag. These peptides may create confounding artifacts when IgM Abs are used for epitope mapping studies. Nonetheless, the peptides may have both experimental and therapeutic utility.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Maddaloni, C. Cooke, R. Wilkinson, A. V. Stout, L. Eng, and S. H. Pincus
Immunological Characteristics Associated with the Protective Efficacy of Antibodies to Ricin
J. Immunol., May 15, 2004; 172(10): 6221 - 6228.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. Masuoka
Surface Glycans of Candida albicans and Other Pathogenic Fungi: Physiological Roles, Clinical Uses, and Experimental Challenges
Clin. Microbiol. Rev., April 1, 2004; 17(2): 281 - 310.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
T. Jouault, C. Fradin, F. Dzierszinski, M. Borg-Von-Zepelin, S. Tomavo, R. Corman, P.-A. Trinel, J.-P. Kerckaert, and D. Poulain
Peptides that mimic Candida albicans-derived {beta}-1,2-linked mannosides
Glycobiology, August 1, 2001; 11(8): 693 - 701.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.